Cargando…

Effect of Histological Inflammation on Total and Free Serum Prostate-Specific Antigen Values in Patients Without Clinically Detectable Prostate Cancer

PURPOSE: We are often confronted with patients in the "gray zone" (prostate-specific antigen [PSA]<10 ng/mL) whose biopsies reveal no malignancy but only inflammation. We investigated the relationship between histological inflammation and total PSA (tPSA), free PSA (fPSA), and percentag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stimac, Goran, Spajic, Borislav, Reljic, Ante, Katusic, Josip, Popovic, Alek, Grubisic, Igor, Tomas, Davor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131081/ https://www.ncbi.nlm.nih.gov/pubmed/25132947 http://dx.doi.org/10.4111/kju.2014.55.8.527

Ejemplares similares

CORRELATION OF EXPRESSION OF TGF- β AND MMP2 BETWEEN PROSTATIC ADENOCARCINOMA AND ADJACENT UNAFFECTED PARENCHYMA
por: Mašić, Silvija, et al.
Publicado: (2022)

Collecting duct carcinoma and endemic nephropathy – case reportS and literature review
por: Knežević, Matej, et al.
Publicado: (2020)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022)

Screening for prostate cancer: a study on the free and total prostate specific antigen
por: Mediu, Ridvana, et al.
Publicado: (2021)

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
por: Wald, N J, et al.
Publicado: (2000)

Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
por: Wenzel, Mike, et al.
Publicado: (2022)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia
por: Abramovic, Irena, et al.
Publicado: (2021)

Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma
por: Thakur, V., et al.
Publicado: (2004)

Prostatic Leiomyoma: An Uncommon Diagnosis Found in Clinically Suspected Cases of Severe Benign Prostatic Hyperplasia Without Elevated Serum Total Prostate-Specific Antigen Levels
por: Qiao, Jesse
Publicado: (2023)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma
por: Duraker, N, et al.
Publicado: (2002)

Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?
por: Rouvière, Olivier, et al.
Publicado: (2022)

Primary osteosarcoma of bladder diverticulum mimicking intradiverticular calculus: a case report
por: Grubišić, Igor, et al.
Publicado: (2011)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

Prostate specific antigen for early detection of prostate cancer: longitudinal study
por: Holmström, Benny, et al.
Publicado: (2009)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Consistency and diagnostic accuracy of 4 assays in the detection of the total and free prostate-specific antigen
por: Deng, Lingyan, et al.
Publicado: (2023)

Histological Typing of Prostate Tumours
por: Harris, M.
Publicado: (1981)

Association of Age-Related Macular Degeneration with Erythrocyte Antioxidant Enzymes Activity and Serum Total Antioxidant Status
por: Plestina-Borjan, Ivna, et al.
Publicado: (2015)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

FOXP3(+) regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer
por: Davidsson, Sabina, et al.
Publicado: (2017)

Sudden Death After Endoscopic Retrograde Cholangiopancreatography (ERCP)—Case Report and Literature Review
por: Hauser, Goran, et al.
Publicado: (2014)

Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
por: Agnihotri, Shalini, et al.
Publicado: (2014)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review
por: Barlow, Melissa, et al.
Publicado: (2022)

Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone
por: Guo, Zhui-Feng, et al.
Publicado: (2021)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
por: Jóhannesson, Vilberg, et al.
Publicado: (2021)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

The use of prostate specific antigen density to predict clinically significant prostate cancer
por: Yusim, Igor, et al.
Publicado: (2020)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Prostate cancer stroma: an important factor in cancer growth and progression
por: Krušlin, Božo, et al.
Publicado: (2015)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Prostate specific antigen /
Publicado: (2001)

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making
por: Nnabugwu, Ikenna I, et al.
Publicado: (2014)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study
por: Shrivastava, Prashant, et al.
Publicado: (2020)

On Chip Immuno-Affinity Profiling of Cancer- and Benign Hyperplasia-Associated Free Prostate Specific Antigen
por: Kosanovic, Maja M., et al.
Publicado: (2011)

Total Extirpation of the Prostate
Publicado: (1901)

Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer
por: Nakamura, Yuichiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sp59ibbvhf6molu962o7rjqs4f